Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

UNCOVERED: Health diabetes - The Untold Story

Experts hail ‘new age of diabetes treatment’ as drug approved on NHS

Teplizumab is approved for children aged eight and over

The Independent UK

Weight-loss drugs may also help boost men’s fertility, study finds

GLP-1 drugs ‘may improve reproductive hormones and semen parameters’, scientists say

The Independent UK

Diabetes, hypertension, cholesterol 'biggest burden' on B30 healthcare

Non-communicable diseases (NCDs) were the biggest burden on the universal healthcare system in fiscal 2025, with high blood pressure, high cholesterol and diabetes accounting for the largest number of patient visits.

Bangkok Post

From analysis to the latest developments in health,
read the most diverse news in one place.

French NutriNet-Santé Study: Natural Food Color Additives Linked to 38–49% Higher Type 2 Diabetes Risk and Increased Cancer Rates

French NutriNet-Santé studies: natural food colorants linked to 38–49% higher T2D risk and 14–32% higher cancer risk. Beta-carotene, curcumin, anthocyanins all implicated.

Medical Daily

The Sweetener Marketed to Diabetics May Be Silently Harming Their Livers. New Research from WashU Explains How.

Washington University Medicine study in Science Signaling: sorbitol converts to fructose in the liver when gut bacteria are overwhelmed, triggering fatty liver disease.

Medical Daily

Going Completely Sugar-Free May Actually Be Making You Less Healthy. A New Study Shows Why Total Elimination Can Backfire.

ENDO 2026 / Dasman Diabetes Institute: sucrose-free low-fat mice diet produced worse blood sugar, insulin resistance, gut dysbiosis, and fatty liver vs. moderate-sucrose controls.

Medical Daily

'Not fat and lazy': painful syndrome prevents women from losing weight

The condition, which affects fat cells, is 'resistant to diet and exercise'.

Newcastle Herald

Read news from The Economist, FT, and more,
with one subscription

GLP-1 Users Walk 560 Fewer Steps Per Day After Starting Ozempic or Wegovy, Fitbit Study Presented at ENDO 2026 Finds

ENDO 2026 study of 753 GLP-1 users found steps dropped 560/day and exercise fell 6 min/day after starting Ozempic or Wegovy. Muscle loss risk is the concern.

Medical Daily

FiberSense Continuous Glucose Monitoring (CGM) System obtains CE mark as commercial launch preparations begin

BASEL, Switzerland, June 17, 2026 /PRNewswire/ -- FiberSense AG ("FiberSense") today announced that the FiberSense Continuous Glucose Monitoring (CGM) System has obtained CE marking under Regulation (EU) 2017/745 as a Class IIb medical device. The system is intended for the continuous monitoring of blood sugar levels and glucose trends in…

AAP

Intensive Lifestyle Changes Reduce Risk of Multimorbidity by 25 Percent in Adults with Prediabetes, 20-Year JAMA Study Reveals

A 20-year NIH study published in JAMA June 15, 2026 found intensive lifestyle changes cut multimorbidity risk by 25% in adults with prediabetes.

Medical Daily

SA:'Lost his will': daughter on trial after parents' death

An elderly woman who died had many medical conditions, and her husband may have "lost his will to live", a lawyer for a daughter accused of killing them says.

AAP

'Lost his will': daughter on trial after parents' death

An elderly woman who died had many medical conditions, and her husband may have "lost his will to live", a lawyer for a daughter accused of killing them says.

AAP

Rethinking Insulin at Its Core: Hua Tu on How Stability Innovation Is Shaping the Next Generation of Diabetes Care

Every individual living with type 1 diabetes understands the discipline the condition demands. Even minor deviations can result in significant fluctuations in glucose levels.

International Business Times

"American Diabetes Association Ejects Researchers from Conference for Sharing Editorial from Its Own Journal"

Aaron Terr (FIRE) reports, based on accounts from various publications. Some excerpts: The incident occurred outside a conference hall where… The post "American Diabetes Association Ejects Researchers from Conference for Sharing Editorial from Its Own Journal" appeared first on Reason.com.

Reason

Get all your
news in one place.

100's of premium titles.
One news app.

AAP

Embattled surgeon lied about reason for fatal surgery

Evidence by the surgeon partner of former Queensland premier Annastacia Palaszczuk has been slammed by an inquiry into the death of one of his patients.

The Guardian - UK

Is the growing use of GLP-1s reshaping ideas of Black beauty?

People across the Black diaspora are increasingly turning to weight-loss drugs. How might this reshape our health, wellbeing and body image?

The Independent UK

New daily weight loss pill helps people shed 10 per cent of body weight

The pill doesn’t have the fasting requirements of many other weight loss drugs

Evening Standard

Think you know how to eat on GLP-1s? You need more than a basic 101…

The weight-loss drug comes with risks, so the right diet is crucial, Dr Federica Amati tells Jessica Burrell

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Muscle-boosting drug could help retain lean tissue when using weight-loss jabs

Researchers found the use of a lab-made antibody can help retain lean body mass when using weight-loss jabs

The Independent UK

Attorneys urge release of mosque leader, saying he's been denied diabetes care in ICE custody

Attorneys for the president of Wisconsin's largest mosque say he is being denied basic medical care for diabetes and has lost 30 pounds since he was taken into custody two months ago by U.S. Immigration and Customs Enforcement

The Guardian - UK

Muscle growth drug ‘could reduce loss of lean tissue’ when using slimming jabs

Trial suggests monoclonal antibody can help retain lean body mass when losing weight with GLP-1 medicines

The Guardian - UK

Triple-action diabetes jab shown to reduce blood sugar and body weight

Retatrutide is designed to control appetite and blood sugar but also increase body’s energy expenditure, unlike other drugs

Medical Daily

Move Over, Ozempic: Scientists Unveiled a New Diabetes Pill That Burns Fat Without Killing Your Appetite — And It Could Be a Breakthrough for Millions of Americans

Researchers at Karolinska Institutet published a study showing a new oral compound activates muscle metabolism to lower blood sugar and torch fat — without nausea, muscle loss, or the side effects plaguing GLP-1 drugs.

Medical Daily

Ozempic Is Now Fighting America's Addiction Crisis — A Massive VA Study Covering 600,000 Veterans Is Rewriting What We Know About Substance Abuse

Drugs like Ozempic and Wegovy — already reshaping obesity treatment — may also slash overdose deaths, ER visits, and alcohol dependence, according to the largest study ever conducted on GLP-1s and addiction.

International Business Times

How Zoe Heineman's Lifelong Fight for Diabetes Access Led Her to The Intersection of Healthcare Research & AI

The economic impact of diabetes continues to be significant. It is estimated that diagnosed diabetes generated approximately $413 billion in total costs in the United States, including direct medical expenses and indirect costs associated with lost productivity.

1 2 3 4 5

People

Annastacia Palaszczuk

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Immigration and Customs Enforcement

Washington University

Karolinska Institutet

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.